RESUMO
@#This is a case report of a 76-year-old Filipino male who presented with a six-year history of a steadily growing left breast mass. The mass was eventually diagnosed to be Invasive Ductal Carcinoma, Anatomic and Prognostic Stage IIIB (T4b cN0 M0), Grade 3, Luminal A. Subsequently, the patient underwent neoadjuvant chemotherapy of doxorubicin/cyclophosphamide and paclitaxel, followed by modified radical mastectomy with axillary lymph node dissection, concluded by post-mastectomy radiation therapy. The patient had complete clinical response to this trimodality therapy. The rarity of this case is juxtaposed and integrated with the present literature on male breast cancer.
Assuntos
Neoplasias da Mama MasculinaRESUMO
Erysipelas is often related to lymphedema, which can occur in up to 60% of cases, with advanced age, radiotherapy, tumor extension, surgical approach, and infections as risk factors. The aim of this study was to present and discuss a series of cases of erysipelas after breast cancer surgery treated in a private mastology clinic over the past ten years. This is a retrospective horizontal cohort study in which we selected all cases of erysipelas after breast cancer surgery from 2009 to 2019. The following were evaluated: number of patients treated with a diagnosis of breast carcinoma with axillary approach, age, surgery performed, adjuvant treatment and treatment of erysipelas, presence of lymphedema, and measurement of circumferences between both arms and associated diseases. A total of 12 cases of breast cancer were treated. In 66.66% of cases, a radical axillary lymphadenectomy was performed, and in 16.66% of cases, only a sentinel lymph node investigation was performed. The average age was 67.6 years. Erysipelas appeared, on average, 43 months after cancer diagnosis. Two deaths were reported due to severe erysipelas leading to sepsis. More studies are still needed on the subject. Of the 12 cases in this study, eight (66.66%) were associated with lymphedema. Only two (16.66%) of the patients in this group who developed erysipelas were not submitted to axillary dissection. The treatment for 50% of the participants in this research was with penicillin G benzathine. There were three relapses, and two patients died during the research period
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Idoso de 80 Anos ou mais , Complicações Pós-Operatórias , Neoplasias da Mama/cirurgia , Erisipela/etiologia , Estudos Retrospectivos , Estudos de Coortes , Neoplasias da Mama Masculina/cirurgia , MastectomiaRESUMO
Breast cancer in men is a rare pathology. The most common clinical presentation is a palpable and painless retroareolar nodule. In men, it is a rare pathology, there are few studies on the matter, where breast cancer trials frequently exclude men. Objective: to present the incidence of breast cancer in men from the "Regional Hospital of Talca" Method: Retrospective and descriptive study of cases of breast cancer in men who have been treated and followed up in the Breast Pathology Unit of the Regional Hospital of Talca from January 1, 2011 to December 31, 2021.Results: There were 9 cases of breast cancer in men. Average age at diagnosis was 63 years, all patients were 50 years of age or older. One hundred percent of patients consulted for a self-palpable breast nodule. Average size on physical examination was 30 mm. The most frequent histology was invasive ductal carcinoma (56%), followed by invasive tubular carcinoma (22%) and ductal carcinoma in situ (11%). Immunohistochemistry was 100% positive for estrogen and progesterone receptor. Surgery in 56% of cases was total mastectomy with axillary dissection, and in 33% it was total mastectomy alone. 4 patients underwent adjuvant treatment with chemotherapy, and just one required a combination of chemotherapy and radiotherapy. During follow-up, only 2 patients died. Conclusion. Breast cancer in men is not very prevalent and the management is extrapolated from large studies in women, we believe that it is essential to have studies in male patients, to really have clarity on the behavior and evolution of the disease.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Carcinoma Ductal de Mama/terapia , Neoplasias da Mama Masculina/terapia , Mastectomia/métodos , Estudos Retrospectivos , Carcinoma Ductal de Mama/patologia , Carcinoma Ductal de Mama/epidemiologia , Terapia Combinada , Neoplasias da Mama Masculina/patologia , Neoplasias da Mama Masculina/epidemiologia , HistologiaRESUMO
SUMMARY OBJECTIVE: Our aim was to investigate the hemogram index parameters and their clinical significance in the evaluation of the inflammatory response of patients with male breast cancer, who are rarely observed in the literature. METHODS: In total, 22 (n=22) healthy male and 28 (n=28) male breast cancer patients without synchronous/metachronous tumors were included in this study. They were grouped as the healthy male control group (Group 1) and the male breast cancer patient group (Group 2). The male breast cancer was divided into two subgroups, namely, early stage [(stage: 0/I/II) (Group 2A)] and late stage [(stage: III/IV) (Group 2B)], and their hemogram index parameters were compared. RESULTS: A significant (p>0.05) increase was observed in neutrophil/lymphocyte ratio (NLR) and·platelet/lymphocyte ratio (PLR) values in the late stage (Group 2B: stage III/IV) compared to the early stage (Group 2A: stage 0/I/II) and healthy control (Group 1) groups. CONCLUSIONS: In male breast cancer patients, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio values were significantly higher as the stage of cancer increased. These readily available simple tests can be used to evaluate the host's inflammatory response in male breast cancer.
Assuntos
Humanos , Masculino , Neoplasias da Mama Masculina/patologia , Neoplasias da Mama Masculina/diagnóstico por imagem , Contagem de Células Sanguíneas , Linfócitos/patologia , Estudos de Casos e Controles , Estudos Retrospectivos , NeutrófilosRESUMO
OBJECTIVE@#To explore the genetic basis for a male with breast cancer and a sister who had deceased of the disease.@*METHODS@#Medical and family history of the proband was collected. Next-generation sequencing was carried out to detect potential variant associated with breast cancer, and Sanger sequencing was used to verify the result.@*RESULTS@#The proband was found to harbor a novel heterozygous c.6018dupT variant of the BRCA2 gene which may cause premature termination of mRNA translation, resulting in a truncated protein. Combined with the family history, the variant was deduced to be a germline mutation. Based on the American College of Medical Genetics and Genomics standards and guidelines, c.6018dupT variant of BRCA2 gene was predicted to be pathogenic (PVS1+PM1/2+PP4).@*CONCLUSION@#The germline variant of the BRCA2 gene probably underlay the breast cancer in this pedigree.
Assuntos
Humanos , Masculino , Proteína BRCA2/genética , Neoplasias da Mama Masculina/genética , Genes BRCA2 , Genômica , Células Germinativas , Mutação em Linhagem GerminativaRESUMO
Solo imágenes(AU)
Assuntos
Humanos , Masculino , Adenocarcinoma/diagnóstico por imagem , Neoplasias da Mama Masculina/diagnóstico por imagemRESUMO
Introducción: El cáncer de mama en el hombre es una patología poco frecuente, que representa el 1% de todos los tumores malignos masculinos y menos del 1% de todos los carcinomas mamarios, cuyas dos características fundamentales son la aparición tardía y la presentación en estadios avanzados. Objetivo: Presentar los 38 casos tratados en el Servicio de Mastología del Hospital Británico de Buenos Aires y comparar los hallazgos con publicaciones anteriores. Material y método: Estudio retrospectivo de pacientes tratados por cáncer de mama en el Servicio desde enero del 1973 a mayo del 2018. Resultados: Edad media 63,9+12.8 años. Tamaño tumoral: 1,9 +0.9 cm. Se realizó Mastectomía radical modificada en 61% de los pacientes. Tipo histológico más frecuente: Ductal Infiltrante en 89,5% de los casos. Hallazgos que concuerdan con publicaciones de otros centros. Discusión: La presentación ocurre en edades avanzadas. La demora en la consulta y la falta de educación sanitaria condicionan las posibilidades de curación. Conclusiones: El cáncer de mama masculino se presenta a avanzada edad, con una importante demora en la consulta y en estadios avanzados. En la actualidad su manejo se extrapola de conductas llevadas a cabo en mujeres.
Introduction: Breast cancer in male patients in an uncommon disease, which represents 1% of all male malignancies and less than 1% of all breast carcinomas, whose two fundamental characteristics are evident: the late appearance and the presentation in advanced stages. Objective: To present the 38 cases treated in the Mastology Service of the British Hospital of Buenos Aires and compare the findings with previous publications. Material and method: Retrospective study of patients treated for breast cancer in the Servic between january 1973 to may 2018. Results: Average age was 63,9 ± 12,8 years. Tumor size: 1.9 ± 0.9 cm. A Modified radical mastectomy was performed in 61% of patients. Most frequent histological type was Infiltrating Ductal Carcinoma in 89,5% of cases. Findings that match publications from other centers. Discussion: Presentation occurs at advanced ages. The delay in consultation and the lack of health education determine the possibilities of healing. Conclusions. Male breast cancer occurs at an advanced age, with a significant delay in the consultation. At present, its management is extrapolated from guidelines carried out in women.
Assuntos
Masculino , Neoplasias da Mama Masculina , Neoplasias da Mama , Mastectomia Radical Modificada , Homens , NeoplasiasRESUMO
Introdução: A enterocolite neutropênica (EN) consiste em ulceração ou necrose da mucosa do ceco, íleo terminal e cólon ascendente, sendo uma condição clínica ocasionada como evento adverso de medicamentos, principalmente em esquemas quimioterápicos. Por ser uma condição com alto índice de mortalidade, o presente relato tem como objetivo contribuir significativamente para discussões que envolvem a EN e a participação da equipe multiprofissional no desfecho clínico. Relato do caso: Paciente do sexo masculino, 75 anos, com diagnóstico de câncer de mama, evoluindo com EN após tratamento com quimioterapia adjuvante. A presença de comorbidades e a idade foram os principais fatores complicadores do quadro de tiflite. Por ser uma toxicidade importante e que pode levar à piora do quadro clínico do paciente com câncer, abordar esse tema é fundamental para um diagnóstico mais rápido, com possibilidade de medidas preventivas. Conclusão: Sendo assim, em virtude do notório aumento dos casos de EN, aponta-se como perspectiva a qualificação da equipe de saúde para a inserção de profissionais ainda mais especializados, capazes de contribuir e identificar os sinais e sintomas relacionados com toxicidades hematológicas, resultado de tratamentos quimioterápicos.
Introduction: Neutropenic enterocolitis (NE) consists of ulceration or necrosis of the mucosa of the cecum, terminal ileum, and ascending colon, being a clinical condition caused by an adverse drug event, mainly in chemotherapy regimens. As it is a high mortality rate condition, this report aims to contribute significantly to discussions involving NE and the participation of the multidisciplinary team in the clinical outcome. Case report: This is a 75-year-old male patient diagnosed with Breast Cancer, who developed EN after treatment with adjuvant chemotherapy. The presence of comorbidities and age were the main complicating factors in typhlitis. As it is an important toxicity and can lead to a worsening of the clinical condition of cancer patients, addressing this issue is essential for a faster diagnosis with the possibility of preventive measures. Conclusion: Therefore, in view of the notorious increase of cases of NE, the perspective of the qualification of the health team is pointed out, for the inclusion of even more specialized professionals capable of contributing and identifying the signs and symptoms related to hematological toxicities, result of chemotherapy treatments.
Introducción: La enterocolitis neutropénica (EN) consiste en la ulceración o necrosis de la mucosa del ciego, íleon terminal y colon ascendente, siendo una condición clínica causada por un evento adverso farmacológico, principalmente en regímenes de quimioterapia. Al tratarse de una afección con una alta tasa de mortalidad, este informe tiene como objetivo contribuir de manera significativa a las discusiones que involucran al EN y la participación del equipo multidisciplinario en el resultado clínico. Relato del caso: Paciente masculino, 75 años, diagnosticado de cáncer de mama, que desarrolló EN después del tratamiento con quimioterapia adyuvante. La presencia de comorbilidades y la edad fueron los principales factores de complicación en Tiflite. Como se trata de una toxicidad importante y puede conducir a un empeoramiento de la condición clínica de los pacientes con cáncer, abordar esta cuestión es fundamental para un diagnóstico más rápido con la posibilidad de medidas preventivas. Conclusión: Por tanto, ante el notable incremento de casos de EN, se apunta la perspectiva de la calificación del equipo de salud, para la inclusión de profesionales aún más especializados capaces de aportar e identificar los signos y síntomas relacionados con las toxicidades hematológicas, un resultado de los tratamientos de quimioterapia.
Assuntos
Humanos , Masculino , Idoso , Neoplasias da Mama Masculina , Enterocolite Neutropênica/tratamento farmacológico , Equipe de Assistência ao Paciente , Quimioterapia Adjuvante , Efeitos Colaterais e Reações Adversas Relacionados a MedicamentosRESUMO
RESUMEN El carcinoma epidermoide primitivo está considerado el tumor más raro de la mama, con una incidencia que representa solo del 0,04 al 0,075 % de todos los tumores malignos de esta localización. Es una variedad de carcinoma metaplásico constituido por células pavimentosas queratinizantes. Se presenta el caso de un paciente de sexo masculino, de 65 años, de color de piel blanca, residente en el municipio Abreus, provincia Cienfuegos, que acudió a la consulta de mastología de la provincia por presentar una tumoración de 5 cms. en el cuadrante superior externo de la mama derecha, de dos meses de evolución. Se realizó exéresis de la tumoración y se recibió informe de la biopsia con el resultado de carcinoma epidermoide poco diferenciado. Actualmente el paciente se sigue en consulta y está libre de metástasis. Por lo inusual del caso se decide su publicación. Se presenta este reporte por ser el primer paciente de sexo masculino, operado de carcinoma epidermoide de mama en la provincia Cienfuegos.
ABSTRACT Primitive epidermoid carcinoma is considered the rarest breast tumor, with an incidence that represents only 0.04 to 0.05 % of all malignant tumors of this location. It is a variety of metaplastic carcinoma made up of keratinizing pavement cells. The case presented is a 65-year-old white male patient, resident in the Abreus municipality, Cienfuegos province who attended the province's mastology clinic for presenting a 5 cm tumor in the upper external quadrant of the right breast, two months in evolution. Exeresis of the tumor was performed and a report of the biopsy was received with the result of poorly differentiated squamous cell carcinoma. Currently the patient is followed in consultation and is free of metastases. Due to the unusual nature of the case, its publication is decided. This report is presented as the first male patient to undergo surgery for squamous cell carcinoma of the breast in the Cienfuegos province.
Assuntos
Humanos , Masculino , Idoso , Carcinoma de Células Escamosas/patologia , Neoplasias da Mama Masculina/patologia , Biópsia , Mama/patologia , Carcinoma de Células Escamosas/cirurgia , Carcinoma de Células Escamosas/diagnóstico , Neoplasias da Mama Masculina/cirurgia , Neoplasias da Mama Masculina/diagnósticoRESUMO
RESUMEN El cáncer de mama en el sexo masculino es una entidad clínica poco frecuente, tiene una presentación unimodal a los 71 años de edad, generalmente se presenta de manera similar a la forma en que se presenta en el sexo femenino. Su causa es poco conocida. Los sarcomas son tumores de componentes mesenquimatoso que constituyen del 0,2-1 % de todos los tumores de mama, y menos del 5 % del total. El sarcoma neurogénico, a su vez, es un tumor extremadamente raro. Representa del 1-2 % aproximadamente, de los tumores de los nervios periféricos con transformación maligna. Debido a la rareza geográfica e histopatológica de este tipo y mucho más en pacientes masculinos se presentó este caso. Paciente masculino de 57 años de edad, con el diagnóstico de un sarcoma de la mama derecha. Se le realizó una mastectomía radical más quimioterapia y radioterapia adyuvante. Los estudios de inmunohistoquímicos permitieron llegar al diagnóstico de sarcoma neurogénico.
ABSTRACT Breast cancer in men (BCM) is a rare clinical entity that has a unimodal presentation at the age of 71 years, and generally presents in a similar way it presents in the female sex. Its etiology remains almost unknown. Sarcomas are tumors of mesenchymal components representing from 0.2 to 1 % of all the breast tumors and less than 5 % of the total. The neurogenic sarcoma is also an extremely rare tumor. It represents around 1-2 % of the peripheral nerves tumors with malignant transformations. Due to location and histopathological rarity of this kind of tumors, much more in male patients, the authors presented the case of a male patient, aged 57 years, with the diagnosis of a left breast sarcoma. He undergone a radical mastectomy plus adjuvant chemotherapy and radiotherapy. The immunohystochemical studies allowed arriving to the diagnosis of neurogenic sarcoma.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Mama/patologia , Imuno-Histoquímica/métodos , Neoplasias da Mama Masculina/cirurgia , Neoplasias da Mama Masculina/diagnóstico , Neoplasias da Mama Masculina/etiologia , Neoplasias da Mama Masculina/patologia , Neoplasias da Mama Masculina/tratamento farmacológico , Neoplasias da Mama Masculina/radioterapia , Mastectomia , Sarcoma de Células Claras , Neurofibrossarcoma/cirurgia , Neurofibrossarcoma/diagnóstico , Neurofibrossarcoma/etiologia , Neurofibrossarcoma/patologiaRESUMO
The luteinizing hormone-releasing hormone/androgen receptor (LHRH/AR) pathway is a promising treatment target in a subgroup of female patients with triple-negative breast cancer (TNBC). However, very little is known about the efficacy of this strategy in male patients with TNBC. In this report, we describe a male patient with AR-positive TNBC who was successfully treated using an LHRH agonist after pretreatment with several lines of chemotherapy and achieved a durable response. We also review the existing evidence supporting LHRH- and AR-targeted therapy for this rare disease.
Assuntos
Feminino , Humanos , Masculino , Masculino , Neoplasias da Mama Masculina , Tratamento Farmacológico , Hormônio Liberador de Gonadotropina , Gosserrelina , Luteína , Doenças Raras , Receptores Androgênicos , Neoplasias de Mama Triplo NegativasRESUMO
Abstract Objective: To assess the relationship between 5α-reductase inhibitors (5ARIs) and the risk of male breast cancer (MBC). Material and Methods: We systematically searched Medline via PubMed, Embase and the Cochrane Library Central Register up to May 2017 to identify published articles related to 5ARIs and the risk of MBC. Results: Summary effect estimates were calculated by a random-effect model, and tests for multivariable-unadjusted pooled risk ratios (RR) and heterogeneity, as well as the sensitivity analyses were conducted to assess publication bias. All four studies were conducted in a quality assessment according to the Newcastle Ottawa Scale system. The strength of association between 5ARIs and the prevalence of MBC was evaluated by using summarized unadjusted pooled RR with a 95% confidence interval [CI]. Four studies involving 595.776 participants, mean age range from 60 to 73.2 years old, were included in a meta-analysis, which produced a summary unadjusted RR of the risk of MBC for the treatment of 5ARIs of 1.16 (95% CI 0.85-1.58, P=0.36) and the multivariable-adjusted RR is 1.03, (95% CI 0.75-1.41, p=0.86). There was no heterogeneity among included studies (I2=0%, P=0.49). Estimates of total effects were generally consistent with the sensitivity. Conclusion: We did not observe a positive association between the use of 5ARIs and MBC. The small number of breast cancer cases exposed to 5ARIs and the lack of an association in our study suggest that the development of breast cancer should not influence the prescribing of 5ARIs therapy.
Assuntos
Humanos , Masculino , Idoso , Neoplasias da Mama Masculina/induzido quimicamente , Inibidores de 5-alfa Redutase/efeitos adversos , Razão de Chances , Inibidores de 5-alfa Redutase/administração & dosagem , Pessoa de Meia-IdadeRESUMO
El cáncer de mama (CM) en el hombre (CMM) es una entidad poco frecuente. Si bien tiene algunas semejanzas con el CM femenino, es una patología con un perfil propio. El objetivo del estudio consiste en conocer las características del CMM y su manejo en nuestro medio. Materiales y métodos: estudio retrospectivo que incluyó pacientes diagnosticados de CMM en tres centros del Uruguay en un período de 15 años. Resultados: se incluyeron 12 pacientes; la mediana de edad fue 68 años; un tercio de ellos tenían antecedentes familiares (AF). Características clínico patológicas: todos los tumores fueron carcinomas ductales con grado histológico (GH) 2-3, » se hallaban en estadio (E) I, la mitad (6) en EII, 6 tuvieron metástasis axilares, 2/3 fueron receptores de estrógeno (RE) / receptores de progesterona (RP) +. Se definieron 3 subtipos biológicos: I) HER2- RE/RP+: 2/3 de los pacientes; II) HER2+: 1/6; y III) triple negativo: 1/6. Todos los pacientes con enfermedad localizada fueron sometidos a mastectomía y la mayoría recibió tratamiento con quimioterapia (QT). La totalidad de quienes presentaron enfermedad localizada RE/RP+ recibieron hormonoterapia adyuvante con buena adherencia y tolerancia. Dos de los once pacientes tratados con criterio radical recayeron en la evolución; el resto permanece en controles o tratamiento sin evidencia de recaída. Conclusión: presentamos una serie de pacientes con CMM, con un perfil similar al reportado en la literatura. La edad de presentación fue superior a la del CM femenino, y la mayoría fueron RE/RP +, HER 2-; sin embargo, en esta serie los pacientes se presentaron en estadio localizado y con tumores de alto grado en una proporción mayor a lo descrito en la literatura.
Breast cancer (BC) in men (MBC) is an uncommon clinical entity. Even though it shares some similarities with female BC, it has a distinctive profile. The objective of this study was to identify the characteristics of MBC and learn how it is managed in our setting. Materials and methods: retrospective study including patients diagnosed with MBC in three centers in Uruguay for a period of 15 years. Results: 12 patients were enrolled; the median age was 68 years; a third of whom had a family history (FH). Clinical and pathological characteristics: all of the tumors were ductal carcinomas of histological grade (HG) 2-3, 1/4 were stage (S) I, half (6) were SII, 6 had axillary metastases, 2/3 were estrogen receptor (ER) / progesterone receptor (PR) +. Three biological subtypes were defined: I) HER2- ER/PR+: 2/3 of patients; II) HER2+: 1/6; and III) triple-negative: 1/6. All patients with localized cancer underwent a mastectomy and most were treated with chemotherapy (CHT). All of those who presented with localized, ER/PR+ cancer received adjuvant hormone therapy, with good adherence and tolerance. Two of the eleven patients treated with radical surgery recurred during evolution; the rest remain in follow-up or treatment without evidence of recurrence. Conclusion: we presented a series of patients with MBC, with a profile similar to the one reported in the literature. Age at presentation was higher than that of female BC, and most were ER/PR +, HER 2-. However, patients in this series presented with breast cancer in the localized stage and high-grade tumors in a higher proportion than is described in the literature.
O câncer de mama (CM) em homens (CMM) é uma entidade clínica incomum. Embora tenha algumas semelhanças com o CM feminino, é uma patologia com o seu próprio perfil. O objetivo deste estudo foi conhecer as características do CMM e seu manejo no nosso meio. Materiais e métodos: estudo retrospectivo com pacientes com diagnóstico de CMM em três centros do Uruguai em um período de 15 anos. Resultados: foram incluídos 12 pacientes; a mediana da idade foi 68 anos; um terço deles tinha antecedentes familiares (AF). Características clínico-patológicas: todos os tumores foram carcinomas ductais de grau histológico (GH) 2-3, 1/4 estavam no estágio (E) I, a metade (6) no EII, 6 apresentaram metástases axilares, 2/3 foram receptores de estrogênio (RE) / receptores de progesterona (RP) +. Foram definidos 3 subtipos biológicos: I) HER2- RE/RP+: 2/3 dos pacientes; II) HER2+: 1/6; e III) triplo-negativo: 1/6. Todos os pacientes com doença localizada foram submetidos a mastectomia e a maioria receberam tratamento com quimioterapia (QT). A totalidade dos que apresentaram doença localizada RE/RP+ recebeu hormonioterapia adjuvante com boa adesão e tolerância. Dois dos onze pacientes tratados com critério radical recaíram na evolução; o resto permanece sob monitoramento ou tratamento sem evidência de recaída. Conclusão: apresentamos uma série de pacientes com CMM, com um perfil semelhante ao descrito na literatura. A idade de apresentação foi maior do que para o CM feminino, e a maioria foram RE/RP +, HER 2-; entretanto, os pacientes desta série apresentaram-se com estágio localizado e tumores de alto grau em uma proporção maior do que a descrita na literatura.
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Carcinoma Ductal de Mama , Neoplasias da Mama Masculina/cirurgia , Neoplasias da Mama Masculina/diagnóstico , Neoplasias da Mama Masculina/tratamento farmacológico , Antineoplásicos/uso terapêutico , Recidiva , Evolução Clínica , Estudos Retrospectivos , Quimioterapia Adjuvante , Neoplasias da Mama Masculina/patologia , Neoplasias da Mama Masculina/radioterapia , Terapia NeoadjuvanteRESUMO
El cáncer mamario en hombres es una enfermedad poco frecuente. Sólo representa 1 por ciento de todos los cánceres de mama y es responsable del 0,1 por ciento de las muertes por cáncer en el hombre. Su incidencia se ha incrementado en los últimos 25 años. Generalmente la forma de presentación de la enfermedad es una masa indolora, retroareolar, con retracción del pezón o no. La enfermedad en estadios avanzados (etapa III-IV) ocurre en más del 40 por ciento de los pacientes. La variedad histopatológica más frecuente es el carcinoma ductal infiltrante y el tratamiento de elección es la mastectomía radical modificada con vaciamiento axilar. El objetivo de este trabajo es la presentación de dos casos diagnosticados y tratados en el Hospital Salvador Allende, además de actualizar el tema(AU)
Breast cancer in men is a rare disease. It accounts only for 1 percent of all breast cancers and is responsible for 0.1 percent of cancer deaths in men. Its incidence has increased in the last 25 years. Generally speaking, the form of presentation of the disease is a painless mass, which is retroareolar, with retraction of the nipple or without it. The disease in advanced stages (stages III-IV) occurs in more than 40 percent of patients. The most frequent histopathological variety is the infiltrating ductal carcinoma and the treatment of choice is modified radical mastectomy with axillary dissection. The objective of this work is the presentation of two cases diagnosed and treated at Salvador Allende Hospital, in addition to updating the topic(AU)
Assuntos
Humanos , Masculino , Pessoa de Meia-Idade , Idoso , Neoplasias da Mama Masculina/diagnóstico , Neoplasias da Mama Masculina/diagnóstico por imagem , Mastectomia/métodos , Biópsia/métodos , Fatores de RiscoRESUMO
Breast cancer in males is a relatively rare entity. In the sub-region, several reports indicate a higher incidence rate compared to other regions in the world. For many years, management strategies were derived from evidence based protocols established for managing female breast cancer. There are however,differences in the epidemiology, presentation, molecular profiles and response to therapies including chemotherapy, hormonal and targeted therapies. Outcomes even though mirroring female breast cancer may actually exhibit differences dependent onstage, race, prognostic and economic variables. The lack of large randomized trials on this subject has resulted in ad hoc management practices across the globe. With new information from renewed interest in the subject, screening and diagnostic guidelines are being established for high-risk groups and we expect to see improvement in outcomes for patients with male breast cancer. This article attempts to bring to light a summary of the current interest, recommendations and controversies in the management of male breast cancer
Assuntos
Neoplasias da Mama Masculina/diagnóstico , Neoplasias da Mama Masculina/epidemiologia , Neoplasias da Mama Masculina/patologia , Neoplasias da Mama Masculina/radioterapia , Gana , Terapia de Reposição Hormonal , HomensRESUMO
O câncer de mama masculino é uma doença rara que representa cerca de 1% de todos os cânceres em homens. A etiologia é desconhecida, porém, existem fatores de risco associados tais como a susceptibilidade genética, endócrina, ocupacional, obesidade, exposição à radiação e a fatores ambientais, dentre outros. A apresentação clínica mais comum é a presença de nódulo doloroso, geralmente subareolar. A raridade da doença e o baixo índice de suspeição clínica, tanto de médicos quanto de pacientes, faz com que exista um longo atraso no diagnóstico da doença, com consequente demora do encaminhamento ao especialista, levando a piora no prognóstico do paciente. Deste modo, foi realizada uma revisão de literatura acerca do tema, com ênfase na abordagem do câncer de mama masculino na atenção primária, dentro dos aspectos epidemiológicos, fatores de risco, manifestações clínicas e encaminhamento precoce ao especialista no intuito de capacitar profissionais de saúde, consequentemente, aumentar a suspeita clínica desta neoplasia. Foram utilizados literatura médica nacional e internacional de base e artigos científicos em língua estrangeira (inglês), publicados no período compreendido entre 2000 a 2017, buscados nas seguintes bibliotecas eletrônicas: PUBMED e SCIELO com as palavras chaves: Atenção primaria, Saúde do homem; Neoplasia de mama masculina; Epidemiologia; Fatores de risco; Sinais e sintomas
Male breast cancer is a rare disease. It is 1% of all cancers in men. The etiology is unknown, but it is associated to risk factors, like genetic susceptibility, endocrine, obesity, occupational, radiation exposure and environmental factors, among others. The most commom clinical presentation is the presence of a painful nodule, frequently localized to the subareolar region. The rarity of the disease and the low rate of clinical suspicion, of both physicians and patients, cause along delay in the diagnosis of the disease, with consequent delay of the referral to the specialist, leading to worsening of the patient's prognosis. This review of the literature aims to describe male breast cancer, with emphasis on its approach in primary care, the epidemiological aspects, risk factors, clinical manifestations and early referral to the specialist. The purpose of this study is to train health professionals and increase the good clinical approach and suspicion of this neoplasm. We used national and international medical literature and scientific articles in English and Portuguese languages, published between 2000 and 2017, searched in the following electronic libraries: PUBMED and SCIELO with the keywords: Primary health care; Men's health; Male Breast Neoplasms; Epidemiology; Risk factors; Signals and symptoms
Assuntos
Humanos , Masculino , Atenção Primária à Saúde , Encaminhamento e Consulta , Neoplasias da Mama Masculina , Prognóstico , Fatores de Risco , Neoplasias da Mama Masculina/diagnóstico , Doenças Raras , Diagnóstico TardioRESUMO
O presente estudo avaliou as estratégias de enfermagem para práticas promotoras de saúde a homens frente ao câncer da mama masculina na atenção básica, mesmo considerado raro, o câncer da mama masculina merece maior atenção por parte dos profissionais de saúde e órgãos governamentais responsáveis pela elaboração das políticas públicas delineadoras dos modelos de atenção, pois o mesmo apresenta repercussões emocionais, sociais e físicas decorrentes do adoecimento e do tratamento para os usuários e a família, na dependência da fase em que for diagnosticado. Trata-se uma pesquisa de campo com abordagem metodológica da Pesquisa Convergente Assistencial (PCA), que possibilita a integração de métodos de pesquisa científica à prática assistencial, onde foi realizada uma entrevista individual com um homem com câncer de mama gerando um caso mobilizador que foi apresentado as 12 enfermeiras da Estratégia Saúde da Família (ESF) de Saquarema após as mesmas responderem um questionário sobre o seu entendimento a cerca do câncer da mama em homens. Desta forma as enfermeiras da baixada litorânea pontuaram as possíveis ações/ estratégias que poderiam desenvolver, a fim de favorecer a criação de um plano de promoção da saúde para homens frente ao câncer da mama masculina, destacados como: Capacitação e Conscientização dos profissionais sobre o tema, Elaboração de cartazes, panfletos e palestras sobre o câncer de mama masculino para os usuários da rede, Utilização das mulheres como multiplicadoras de informação e a Informação ao público masculino além dos muros da instituição e estratégia de captação do público masculino. Sendo essas, estratégias que podem ser implementadas na atenção básica a fim de informar e conscientizar os usuários da rede.(AU)
Assuntos
Humanos , Masculino , Adulto , Neoplasias da Mama Masculina/diagnóstico , Neoplasias da Mama Masculina/enfermagem , Neoplasias da Mama Masculina/prevenção & controle , Promoção da Saúde , Saúde do Homem , Atenção Primária à SaúdeRESUMO
El cáncer de mama en hombres es una entidad poco frecuente y muy poco estudiada. Su pronóstico y manejo aun distan de lo ideal y de lo que se ha logrado en cáncer mamario en mujeres. Los tumores neuroendocrinos de la mama son aún más raros. Su comportamiento tiende en la mayoría de los casos a ser incierto y su manejo controversial. El reporte de caso se trata de un paciente masculino de 67 años, con historia de aparición de masa en mama derecha, con diagnóstico inicial de tumor mal diferenciado, con posterior inmunohistoquimica que informa tumor neuroendocrino primario de la mama. El diagnóstico temprano de cáncer de mama en hombres implica un verdadero reto para los sistemas de salud. Debemos conocer más sobre su fisiopatología y factores de riesgo(AU)
The early diagnosis of breast cancer in men represents a real challenge for the health systems. Therefore, our knowledge about its physiopathology and risk factors must be expandedBreast cancer in men is a rare and poorly studied malady. The prognosis and management is far from being ideal and from the achievements of the female breast cancer treatment. Even rare are neuroendocine breast tumors. In most of cases, its behavior is uncertain and its management is controversial. This was the report of a male patient aged 67 years, with history of right breast mass, initially diagnosed as a poorly differentiated tumor with later immunohistochemical test that reported the existence of a primary neuroendocrine breast tumor(AU)
Assuntos
Humanos , Masculino , Idoso , Neoplasias da Mama Masculina/diagnóstico por imagem , Mastectomia Radical Modificada/efeitos adversos , Tumores Neuroendócrinos/cirurgia , Neoplasias Unilaterais da Mama/radioterapiaRESUMO
Se realizó un estudio observacional, descriptivo y longitudinal de 95 pacientes (90 mujeres y 5 hombres), atendidos en la consulta de Mastología del Hospital Oncológico Provincial Docente Conrado Benítez de Santiago de Cuba, desde enero de 2014 hasta febrero de 2015, con vistas a determinar los factores sociales que inciden en el incremento del cáncer de mama y, a partir de entonces, elaborar una propuesta de acciones que permitan potenciar la promoción y educación para la salud. Fueron aplicados técnicas cualitativas que permitieron conocer las experiencias, las actitudes, los pensamientos y las reflexiones de los participantes expertos. Se observó que la mayoría de los pacientes (67,4 por ciento) desconocían lo relacionado con las actividades de promoción de salud desarrolladas por las organizaciones de masas, así como el pobre desempeño de los médicos de familia en este sentido
An observational, descriptive and longitudinal study of 95 patients (90 women and 5 men), assisted in the Breast Service of Conrado Benítez Teaching Provincial Cancer Hospital in Santiago de Cuba, was carried out from January, 2014 to February, 2015, aimed at determining the social factors that impact in the increase of breast cancer and, from that time on, elaborate a proposal of actions that allow the promotion and education for health. Some qualitative techniques were implemented that allowed to know the experiences, attitudes, thoughts and reflections of the expert participants. It was observed that most of the patients (67.4 percent) ignored everything related to the activities of health promotion developed by the masses organizations, as well as the poor performance of the family doctors in this sense
Assuntos
Humanos , Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Idoso , Neoplasias da Mama/epidemiologia , Neoplasias da Mama Masculina , Fatores Sociológicos , Promoção da Saúde , Epidemiologia Descritiva , Estudos Longitudinais , Vulnerabilidade Social , Estudo ObservacionalRESUMO
No abstract available.